MMP9 and prostate carcinoma: SENP1 is linked to prostate cancer progression because SENP1 regulation of matrix metallopeptidase 2 (MMP2) and matrix metallopeptidase 9 (MMP9) through the hypoxia-inducible factor 1-alpha (HIF-1α) signaling pathway promotes progression [114].